Published in J Cell Physiol on May 01, 2015
Traumatic brain injury in later life increases risk for Parkinson disease. Ann Neurol (2015) 1.71
Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities. Neuropsychiatr Dis Treat (2015) 1.31
Traumatic brain injury and NADPH oxidase: a deep relationship. Oxid Med Cell Longev (2015) 0.85
Combination therapies for neurobehavioral and cognitive recovery after experimental traumatic brain injury: Is more better? Prog Neurobiol (2016) 0.84
Neuroinflammatory responses to traumatic brain injury. Neuropsychiatr Dis Treat (2015) 0.81
Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases. Front Neurosci (2016) 0.78
Traumatic Brain Injury Leads to Development of Parkinson's Disease Related Pathology in Mice. Front Neurosci (2016) 0.77
Calcium: Alpha-Synuclein Interactions in Alpha-Synucleinopathies. Front Neurosci (2016) 0.76
Role of neurotoxicants and traumatic brain injury in α-synuclein protein misfolding and aggregation. Brain Res Bull (2016) 0.76
Utilizing pharmacotherapy and mesenchymal stem cell therapy to reduce inflammation following traumatic brain injury. Neural Regen Res (2016) 0.75
Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases. Transl Neurodegener (2017) 0.75
Quantitative proteomics in A30P*A53T α-synuclein transgenic mice reveals upregulation of Sel1l. PLoS One (2017) 0.75
Detection of autoantibodies to potentially amyloidogenic protein, gamma-synuclein, in the serum of patients with amyotrophic lateral sclerosis and cerebral circulatory disorders. Dokl Biochem Biophys (2017) 0.75
Inhibition of the integrated stress response reverses cognitive deficits after traumatic brain injury. Proc Natl Acad Sci U S A (2017) 0.75
Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry (2008) 7.20
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron (2000) 6.92
Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc Natl Acad Sci U S A (2000) 5.83
Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science (2010) 5.42
Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol (2006) 5.40
Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci (2001) 5.32
Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron (2010) 4.76
Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci (2010) 3.81
Pathophysiology of traumatic brain injury. Br J Anaesth (2007) 3.06
α-Synuclein: membrane interactions and toxicity in Parkinson's disease. Annu Rev Cell Dev Biol (2010) 2.93
Chronic neuropathologies of single and repetitive TBI: substrates of dementia? Nat Rev Neurol (2013) 2.84
Animal models of traumatic brain injury. Nat Rev Neurosci (2013) 2.75
Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. Proc Natl Acad Sci U S A (2004) 2.62
Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models. Dis Model Mech (2009) 2.16
Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans. Exp Neurol (2007) 2.15
Genetics of Parkinson's disease. Cold Spring Harb Perspect Med (2012) 1.96
Head injury and Parkinson's disease risk in twins. Ann Neurol (2006) 1.93
Heat-shock protein 70 modulates toxic extracellular α-synuclein oligomers and rescues trans-synaptic toxicity. FASEB J (2010) 1.90
Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants. Ann N Y Acad Sci (2000) 1.67
α-Synuclein in Parkinson's disease. Cold Spring Harb Perspect Med (2012) 1.62
Head trauma preceding PD: a case-control study. Neurology (2003) 1.54
Awakenings from persistent vegetative state: report of three cases with parkinsonism and brain stem lesions on MRI. J Neurol Neurosurg Psychiatry (2003) 1.47
The new stereological methods for interpreting functional morphology from slices of cells and organs. Exp Physiol (1991) 1.47
The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates. Neuropathology (2007) 1.36
Long-term upregulation of inflammation and suppression of cell proliferation in the brain of adult rats exposed to traumatic brain injury using the controlled cortical impact model. PLoS One (2013) 1.33
Severity of controlled cortical impact traumatic brain injury in rats and mice dictates degree of behavioral deficits. Brain Res (2009) 1.27
Induction of oxidative and nitrosative damage leads to cerebrovascular inflammation in an animal model of mild traumatic brain injury induced by primary blast. Free Radic Biol Med (2013) 1.23
α-Synuclein in CSF of patients with severe traumatic brain injury. Neurology (2013) 1.20
Nigrostriatal overabundance of α-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity. Acta Neuropathol (2012) 1.10
The pathophysiology of traumatic brain injury at a glance. Dis Model Mech (2013) 1.09
Traumatic brain injury in adult rats causes progressive nigrostriatal dopaminergic cell loss and enhanced vulnerability to the pesticide paraquat. J Neurotrauma (2011) 1.08
Frontal cortex neuropathology in dementia pugilistica. J Neurotrauma (2012) 1.08
Mitochondria in traumatic brain injury and mitochondrial-targeted multipotential therapeutic strategies. Br J Pharmacol (2012) 1.07
Quantifying the pathology of neurodegenerative disorders: quantitative measurements, sampling strategies and data analysis. Histopathology (2003) 1.03
Inhibition of tyrosine hydroxylase expression in alpha-synuclein-transfected dopaminergic neuronal cells. Neurosci Lett (2004) 1.00
Immediate, but not delayed, microsurgical skull reconstruction exacerbates brain damage in experimental traumatic brain injury model. PLoS One (2012) 0.99
A quantitative study of α-synuclein pathology in fifteen cases of dementia associated with Parkinson disease. J Neural Transm (Vienna) (2013) 0.93
Chronic neurodegenerative consequences of traumatic brain injury. Restor Neurol Neurosci (2014) 0.92
Slowing down after a mild traumatic brain injury: a strategy to improve cognitive task performance? Arch Clin Neuropsychol (2011) 0.90
The significance of mild traumatic brain injury to cognition and self-reported symptoms in long-term recovery from injury. J Clin Exp Neuropsychol (2008) 0.90
The role of Ser129 phosphorylation of α-synuclein in neurodegeneration of Parkinson's disease: a review of in vivo models. Rev Neurosci (2013) 0.89
Over-expression of alpha-synuclein in the nervous system enhances axonal degeneration after peripheral nerve lesion in a transgenic mouse strain. J Neurochem (2010) 0.89
The role of alpha-synuclein oligomerization and aggregation in cellular and animal models of Parkinson's disease. PLoS One (2012) 0.89
Review: the long-term consequences of microglial activation following acute traumatic brain injury. Neuropathol Appl Neurobiol (2013) 0.88
α-Synuclein levels are elevated in cerebrospinal fluid following traumatic brain injury in infants and children: the effect of therapeutic hypothermia. Dev Neurosci (2010) 0.88
CSF Bcl-2 and cytochrome C temporal profiles in outcome prediction for adults with severe TBI. J Cereb Blood Flow Metab (2011) 0.86
α-Synuclein elevation in human neurodegenerative diseases: experimental, pathogenetic, and therapeutic implications. Mol Neurobiol (2012) 0.84
αSynuclein and Mitochondrial Dysfunction: A Pathogenic Partnership in Parkinson's Disease? Parkinsons Dis (2012) 0.84
Traumatic brain injury in operation enduring freedom/operation iraqi freedom: a primer. Nurs Clin North Am (2010) 0.82
Neurochemical profile of dementia pugilistica. J Neurotrauma (2013) 0.82
α-Synuclein is a pathological link and therapeutic target for Parkinson's disease and traumatic brain injury. Med Hypotheses (2013) 0.82
Modern chronic traumatic encephalopathy in retired athletes: what is the evidence? Neuropsychol Rev (2013) 0.82
Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease. Drugs Aging (2014) 0.79
Parkinson's disease, parkinsonism, and traumatic brain injury. Crit Rev Clin Lab Sci (2013) 0.78
Parkinson's disease: an inquiry into the etiology and treatment. Neurol Int (2011) 0.78
Chronic traumatic encephalopathy: a critical appraisal. Neurocrit Care (2014) 0.77
Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke (2004) 2.49
Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke (2004) 2.40
Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J Neurochem (2004) 1.99
Mobilized peripheral blood cells administered intravenously produce functional recovery in stroke. Cell Transplant (2003) 1.81
Postischemic brain injury is exacerbated in mice lacking the kinin B2 receptor. Hypertension (2006) 1.80
Cord blood rescues stroke-induced changes in splenocyte phenotype and function. Exp Neurol (2006) 1.69
Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev (2005) 1.67
Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. J Hematother Stem Cell Res (2003) 1.66
The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders. Prog Neurobiol (2011) 1.61
Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS One (2007) 1.58
Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplant (2002) 1.57
Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction. Cell Transplant (2004) 1.53
Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. Stem Cells Dev (2010) 1.51
From the basics to application of cell therapy, a steppingstone to the conquest of neurodegeneration: a meeting report. Med Sci Monit (2009) 1.50
Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats. BMC Neurol (2004) 1.47
Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington's disease: a preliminary study. Neurotox Res (2003) 1.46
Implications of blood-brain barrier disruption in ALS. Amyotroph Lateral Scler (2008) 1.45
Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS. Brain Res (2007) 1.43
Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection. Exp Neurol (2004) 1.40
CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide. Eur J Immunol (2005) 1.38
Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant (2006) 1.38
Ziprasidone-induced oculogyric crisis. J Am Acad Child Adolesc Psychiatry (2003) 1.37
Cell-based therapy in ischemic stroke. Expert Rev Neurother (2008) 1.33
Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke. BMC Neurosci (2009) 1.33
Long-term upregulation of inflammation and suppression of cell proliferation in the brain of adult rats exposed to traumatic brain injury using the controlled cortical impact model. PLoS One (2013) 1.33
Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications. Int J Mol Sci (2013) 1.31
Severity of controlled cortical impact traumatic brain injury in rats and mice dictates degree of behavioral deficits. Brain Res (2009) 1.27
Microglia activation as a biomarker for traumatic brain injury. Front Neurol (2013) 1.23
Neurodegeneration in the rat hippocampus and striatum after middle cerebral artery occlusion. Brain Res (2002) 1.22
Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic-ischemic rats. J Cereb Blood Flow Metab (2008) 1.22
Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior. J Hematother Stem Cell Res (2003) 1.21
Notch-induced rat and human bone marrow stromal cell grafts reduce ischemic cell loss and ameliorate behavioral deficits in chronic stroke animals. Stem Cells Dev (2009) 1.18
Toward cell therapy using placenta-derived cells: disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table. Stem Cells Dev (2010) 1.17
Peripheral injection of human umbilical cord blood stimulates neurogenesis in the aged rat brain. BMC Neurosci (2008) 1.16
Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke. Prog Neurobiol (2008) 1.15
Cytokines produced by cultured human umbilical cord blood (HUCB) cells: implications for brain repair. Exp Neurol (2006) 1.14
Potential of stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic. Regen Med (2008) 1.13
Human umbilical cord blood cell grafts for brain ischemia. Cell Transplant (2009) 1.12
The immunology of traumatic brain injury: a prime target for Alzheimer's disease prevention. J Neuroinflammation (2012) 1.12
Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha. BMC Neurosci (2010) 1.11
Infusion of human umbilical cord blood ameliorates neurologic deficits in rats with hemorrhagic brain injury. Ann N Y Acad Sci (2005) 1.11
Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury. Cell Transplant (2006) 1.10
Human umbilical cord blood progenitors: the potential of these hematopoietic cells to become neural. Stem Cells (2005) 1.09
Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer mice. Stem Cells Dev (2008) 1.08
In vivo animal stroke models: a rationale for rodent and non-human primate models. Transl Stroke Res (2013) 1.07
Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose. PLoS One (2008) 1.06
Transplantation of umbilical cord blood stem cells for treating spinal cord injury. Stem Cell Rev (2011) 1.06
Cyclosporine-A as a neuroprotective agent against stroke: its translation from laboratory research to clinical application. Neuropeptides (2011) 1.06
Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis. Hypertension (2003) 1.05
Intravenous grafts of amniotic fluid-derived stem cells induce endogenous cell proliferation and attenuate behavioral deficits in ischemic stroke rats. PLoS One (2012) 1.05
Mesenchymal stem cells in autoimmune disease. Stem Cells Dev (2004) 1.03
cAMP differentially regulates gamma-globin gene expression in erythroleukemic cells and primary erythroblasts through c-Myb expression. Biochem Biophys Res Commun (2006) 1.02
Quantitative analyses of matrix metalloproteinase activity after traumatic brain injury in adult rats. Brain Res (2009) 1.02
Cell therapy for stroke: emphasis on optimizing safety and efficacy profile of endothelial progenitor cells. Curr Pharm Des (2012) 1.01
Amnion: a potent graft source for cell therapy in stroke. Cell Transplant (2009) 1.01
The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood-derived stem cells. Cell Transplant (2010) 1.00
Stroke-induced migration of human umbilical cord blood cells: time course and cytokines. Stem Cells Dev (2005) 1.00
Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis. Hum Gene Ther (2006) 0.99
Mankind's first natural stem cell transplant. J Cell Mol Med (2010) 0.99
Recent Studies Assessing the Proliferative Capability of a Novel Adult Stem Cell Identified in Menstrual Blood. Open Stem Cell J (2011) 0.99
Immediate, but not delayed, microsurgical skull reconstruction exacerbates brain damage in experimental traumatic brain injury model. PLoS One (2012) 0.99
Amyotrophic lateral sclerosis: a neurovascular disease. Brain Res (2011) 0.99
Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons. BMC Neurosci (2008) 0.98
Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine. Depress Anxiety (2002) 0.98
Nutraceuticals synergistically promote proliferation of human stem cells. Stem Cells Dev (2006) 0.98
Stem cell recruitment of newly formed host cells via a successful seduction? Filling the gap between neurogenic niche and injured brain site. PLoS One (2013) 0.98
Amniotic fluid as a rich source of mesenchymal stromal cells for transplantation therapy. Cell Transplant (2010) 0.97
Human umbilical cord blood cells express neural antigens after transplantation into the developing rat brain. Cell Transplant (2002) 0.97
Injectable VEGF hydrogels produce near complete neurological and anatomical protection following cerebral ischemia in rats. Cell Transplant (2010) 0.97
Novel cell therapy approaches for brain repair. Prog Brain Res (2006) 0.97
Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression. J Neuroinflammation (2008) 0.95
Positive effect of transplantation of hNT neurons (NTera 2/D1 cell-line) in a model of familial amyotrophic lateral sclerosis. Exp Neurol (2002) 0.95
Cord blood mesenchymal stem cells: Potential use in neurological disorders. Stem Cells Dev (2006) 0.95
Vasculogenesis in experimental stroke after human cerebral endothelial cell transplantation. Stroke (2013) 0.95